D-0119-2021 Class III Terminated
FDA drug recall D-0119-2021 was initiated by Teligent Pharma, Inc. on Nov 5, 2020 and is designated Class III. Reason for recall: Superpotent and Subpotent; low and high assay results The recall status is terminated (terminated Aug 16, 2024). Affected quantity: 20160 tubes.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 9, 2020
- Initiation Date
- Nov 5, 2020
- Termination Date
- Aug 16, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 20160 tubes
Product description
Clobetasol Propionate Ointment USP 0.05%, Net Wt. 50 grams, Rx Only, Teligent Pharma. Inc. Buena, NJ 08310 NDC 52565-039-60
Reason for recall
Superpotent and Subpotent; low and high assay results
Distribution pattern
Nationwide
Code information
Lot Number: 12597, exp. date 12/2020
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0119-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026